Immutep advances autoimmune program while reviewing efti pathway
from Latest Interviews - Finance News Network Hosted by Finance News Network
18 May 2026 - Mark Voigt, CEO and Executive Director of Immutep, discusses the company’s strategic priorities following the discontinuation of its Phase III TACTI-004 lung cancer trial
Embed this episode
No transcript yet.
Frequently asked questions
When was this Latest Interviews - Finance News Network episode published?
This episode was published on May 18, 2026.
Can I download this Latest Interviews - Finance News Network episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.